🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the Single Rising Dose (SRD) part (trial part 1) i...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2017-01-12
Trial ID
NCT03004404
This is a Phase 3b, randomized, double-blind, placebo-controlled, multicent...
Status
Terminated
Location
University of Maryland Medical Center
Start Date
2022-06-24
Trial ID
NCT05228834
Treatments Being Tested
SRD-Part: To investigate safety, tolerability, pharmacokinetics and pharmac...
Status
Terminated
Location
Charité - Universitätsmedizin Berlin
Start Date
2020-07-21
Trial ID
NCT04445090
Treatments Being Tested
This first-in man trial is designed to investigate the safety and tolerabil...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2017-11-02
Trial ID
NCT03315936
To investigate safety, tolerability, and pharmacokinetics of BI 425809 foll...
Status
Completed
Location
1346.1.1 Boehringer Ingelheim Investigational Site
Start Date
2014-03-20
Trial ID
NCT02068690
Treatments Being Tested
To address the clinical need for improving early response rates, maintainin...
Status
Not Yet Recruiting
Location
Wuhan Union Hospital
Start Date
2025-12-01
Trial ID
NCT07189910
Treatments Being Tested
* To investigate the influence of different doses of BI 1026706 on the prim...
Status
Completed
Location
1320.3.1 Boehringer Ingelheim Investigational Site
Start Date
2014-01-21
Trial ID
NCT02037165
Treatments Being Tested